Cargando…
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
BACKGROUND: Drug discovery for the neglected tropical disease schistosomiasis has a high priority. Anticancer drugs, especially protein kinase inhibitors, might serve as a starting point for drug discovery owing to the importance of protein kinases in helminth growth and development. Furthermore, th...
Autores principales: | Cowan, Noemi, Keiser, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533769/ https://www.ncbi.nlm.nih.gov/pubmed/26265386 http://dx.doi.org/10.1186/s13071-015-1023-y |
Ejemplares similares
-
Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni
por: Pasche, Valérian, et al.
Publicado: (2018) -
Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
por: Panic, Gordana, et al.
Publicado: (2015) -
Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
por: Panic, Gordana, et al.
Publicado: (2015) -
Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni
por: Buchter, Valentin, et al.
Publicado: (2021) -
Naturally Occurring Cardenolides Affecting Schistosoma mansoni
por: Keiser, Jennifer, et al.
Publicado: (2020)